查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571988

世界论文诊断市场

Paper Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 174 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，美国的全球论文诊断市场预计将达到 138 亿美元

全球纸本诊断市场预计 2023 年为 88 亿美元，预计到 2030 年将达到 138 亿美元，2023 年至 2030 年复合年增长率为 6.6%。横向流动化验套件是本报告分析的细分市场之一，预计复合年增长率为 6.2%，到分析期结束时将达到 67 亿美元。在分析期间，量油尺细分市场的复合年增长率预计为 7.4%。

美国市场预计24亿美元，中国预计复合年增长率6.2%

预计 2023 年美国纸本诊断市场规模将达 24 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达22亿美元，2023-2030年分析期间复合年增长率为6.2%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 5.8% 和 5.6%。在欧洲，德国的复合年增长率预计为 5.1%。

全球论文诊断市场—主要趋势与驱动因素总结

什么是论文诊断？

纸本诊断是指使用纸本设备进行医学测试和疾病检测。这些装置通常由纤维素和其他多孔材料製成，价格便宜、易于使用且一次性。作为传统实验室测试的经济有效的替代方案，论文诊断越来越受欢迎，特别是在资源有限的环境中。它通常用于侧流检测，例如妊娠测试和疟疾、COVID-19 和 HIV 等感染疾病的快速诊断测试。这些设备简单且便携，非常适合及时诊断至关重要的就地检验。此外，Essay Diagnostics 可生物分解性、环保，且操作所需的试剂和设备最少。

科技进步如何提升诊断论文的能力？

技术的进步大大扩展了纸本诊断的应用范围。微流体的创新使得更复杂的诊断方法得以开发，这些方法可以透过使少量流体流过蚀刻在纸张上的通道来同时执行多项测试。将比色、电化学和萤光检测方法纳入纸本诊断提高了灵敏度和准确性，从而获得更可靠的结果。此外，随着可以检测血液、唾液和尿液中特定生物标记的纸质生物感测器的发展，纸本诊断正在成为早期疾病检测和监测的强大工具。这些进步为个人化医疗保健开闢了新的可能性，使个人能够家用中进行诊断测试并立即获得结果，而无需实验室。

全球健康倡议和远距医疗趋势如何塑造市场？

技术创新正在改变纸本诊断产业，主要是透过微流体、生物感测器和检测方法的进步。微流体使得能够在小型便携式纸质平台上处理复杂分析的设备得以开发。这些进步使得创建可以同时执行多项测试的设备成为可能，从而大大增加了论文诊断的多功能性。此外，纸本诊断中生物感测器的使用扩大了可检测的病理范围，从感染疾病到糖尿病等慢性病。比色、萤光和电化学检测技术的整合进一步提高了这些测试的准确性和可靠性，增加了它们在已开发市场和新兴市场的吸引力。这些技术突破使得设计出价格实惠的携带式诊断工具成为可能，这些工具可以在资源匮乏的环境中使用，并在医疗环境中提供快速可靠的结果。

纸本诊断市场成长的驱动力是什么？

论文诊断的需求在很大程度上受到全球健康倡议的影响，这些倡议致力于改善偏远和服务不足地区的医疗保健服务。世界卫生组织 (WHO) 和非政府组织等组织越来越多地倡导可在卫生基础设施有限的地区使用负担得起的诊断工具。这些诊断的低成本和便携性使其适合传统实验室测试无法进行或无法进行的环境。这些工具对于及时发现疟疾、结核病和爱滋病毒等疾病至关重要，并有助于减少感染疾病的传播。此外，COVID-19 大流行凸显了家庭检测和远端医疗的重要性，并加速了纸本诊断的采用。

对照护现场诊断的需求不断增加，特别是在医疗基础设施有限的地区，刺激了纸本诊断设备的采用。微流体、生物感测器和检测方法的技术进步显着提高了纸本平台上进行的测试的灵敏度、准确性和范围。此外，全球对经济实惠且永续的医疗保健解决方案的推动增加了对经济高效、便携式和环保诊断的需求。向远距医疗保健和个人化医疗的转变、感染疾病和慢性病盛行率的上升也促进了市场的成长。随着政府、非政府组织和医疗机构继续投资改善医疗服务，特别是在资源匮乏的环境中，纸本诊断市场预计将大幅扩张。

受访企业范例（44家知名企业）

  • Abcam PLC
  • Abingdon Health Ltd.
  • Acon Laboratories, Inc.
  • Alere, Inc.
  • Arkray, Inc.
  • BBI Solutions
  • Bioporto Diagnostics A/S
  • Bio-Rad Laboratories, Inc.
  • Chembio Diagnostic Systems, Inc.
  • Cytodiagnostics Inc.
  • DCN Diagnostics
  • MilliporeSigma
  • NanoHybrids
  • SD Biosensor, Inc.
  • Siemens Healthineers
  • SurModics, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP13853

Global Paper Diagnostics Market to Reach US$13.8 Billion by 2030

The global market for Paper Diagnostics estimated at US$8.8 Billion in the year 2023, is expected to reach US$13.8 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2023-2030. Lateral Flow Assay Kits, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$6.7 Billion by the end of the analysis period. Growth in the Dipsticks segment is estimated at 7.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.4 Billion While China is Forecast to Grow at 6.2% CAGR

The Paper Diagnostics market in the U.S. is estimated at US$2.4 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 6.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.8% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Global Paper Diagnostics Market – Key Trends & Drivers Summarized

What Are Paper Diagnostics and Why Are They Gaining Traction in Healthcare?

Paper diagnostics refers to the use of paper-based devices for medical testing and disease detection. These devices are typically made from cellulose or other porous materials that are inexpensive, easy to use, and disposable. Paper diagnostics has gained popularity, particularly in resource-limited settings, as they provide a cost-effective alternative to traditional laboratory-based tests. They are often used in lateral flow assays, such as pregnancy tests or rapid diagnostic tests for infectious diseases like malaria, COVID-19, or HIV. The simplicity and portability of these devices make them ideal for point-of-care testing, where timely diagnosis is crucial. In addition, paper diagnostics are environmentally friendly, being biodegradable and requiring minimal reagents or equipment for operation.

How Are Technological Advancements Enhancing the Capabilities of Paper Diagnostics?

Technological advancements have greatly expanded the applications of paper diagnostics. Innovations in microfluidics, where small volumes of fluids are directed through channels etched into paper, have made it possible to develop more complex diagnostics that can perform multiple tests simultaneously. The incorporation of colorimetric, electrochemical, and fluorescent detection methods into paper diagnostics has improved their sensitivity and accuracy, allowing for more reliable results. In addition, the development of paper-based biosensors, which can detect specific biomarkers in blood, saliva, or urine, is making paper diagnostics a powerful tool for early disease detection and monitoring. These advancements have opened up new possibilities for personalized healthcare, allowing individuals to perform diagnostic tests at home and receive instant results without the need for a laboratory.

How Are Global Health Initiatives and Remote Healthcare Trends Shaping the Market?

Technological innovations are transforming the paper diagnostics industry, primarily through advancements in microfluidics, biosensors, and detection methods. Microfluidics has allowed the development of devices that can handle complex assays on a small, portable paper platform. These advancements enable the creation of devices that can simultaneously conduct multiple tests, significantly improving the versatility of paper diagnostics. Moreover, the use of biosensors embedded in paper diagnostics has expanded the range of detectable conditions, from infectious diseases to chronic illnesses like diabetes. The integration of colorimetric, fluorescent, and electrochemical detection techniques further improves the accuracy and reliability of these tests, enhancing their appeal in both developed and developing markets. These technological breakthroughs make it possible to design affordable, portable diagnostic tools that can be used in low-resource settings and provide quick, reliable results at the point of care.

What Is Driving Growth in the Paper Diagnostics Market?

The demand for paper diagnostics is heavily influenced by global health initiatives that focus on improving healthcare access in remote and underserved regions. Organizations such as the World Health Organization (WHO) and NGOs are increasingly advocating for affordable diagnostic tools that can be used in areas with limited medical infrastructure. Paper diagnostics, being low-cost and easy to transport, are well-suited to these environments, where traditional laboratory tests may be inaccessible or unaffordable. These tools are crucial for the timely detection of diseases like malaria, tuberculosis, and HIV, helping to curb the spread of infectious diseases. Additionally, the COVID-19 pandemic highlighted the importance of at-home testing and telemedicine, accelerating the adoption of paper diagnostics.

The increasing demand for point-of-care diagnostics, particularly in regions with limited access to healthcare infrastructure, has fueled the adoption of paper-based diagnostic devices. Technological advancements in microfluidics, biosensors, and detection methods have significantly improved the sensitivity, accuracy, and range of tests that can be performed on paper-based platforms. Furthermore, the global push for affordable and sustainable healthcare solutions has increased demand for paper diagnostics, which are cost-effective, portable, and environmentally friendly. The shift toward remote healthcare and personalized medicine, as well as the rising prevalence of infectious diseases and chronic conditions, are also contributing to market growth. As governments, NGOs, and healthcare organizations continue to invest in improving healthcare access, particularly in low-resource settings, the paper diagnostics market is expected to expand significantly.

Select Competitors (Total 44 Featured) -

  • Abcam PLC
  • Abingdon Health Ltd.
  • Acon Laboratories, Inc.
  • Alere, Inc.
  • Arkray, Inc.
  • BBI Solutions
  • Bioporto Diagnostics A/S
  • Bio-Rad Laboratories, Inc.
  • Chembio Diagnostic Systems, Inc.
  • Cytodiagnostics Inc.
  • DCN Diagnostics
  • MilliporeSigma
  • NanoHybrids
  • SD Biosensor, Inc.
  • Siemens Healthineers
  • SurModics, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Paper Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Low-Cost, Point-of-Care Testing Drives Growth in the Paper Diagnostics Market
    • Increasing Focus on Infectious Disease Testing Expands Market Opportunities for Paper-Based Diagnostic Tools
    • Technological Advancements in Microfluidics and Biosensors Enhance the Sensitivity and Accuracy of Paper Diagnostics
    • Growing Popularity of Home Testing Solutions Fuels Demand for User-Friendly, Disposable Paper Diagnostics
    • Rising Consumer Interest in Personalized Medicine and At-Home Diagnostics Strengthens the Business Case for Paper Diagnostics
    • Technological Innovations in Colorimetric and Electrochemical Detection Methods Improve the Accuracy of Paper-Based Tests
    • Growing Need for Rapid Testing During Public Health Crises Fuels Demand for Scalable Paper Diagnostics
    • Increasing Use of Paper Diagnostics in Disease Monitoring and Management Expands Market Potential in Chronic Disease Segments
    • Rising Focus on Sustainability and Biodegradability in Medical Devices Drives Adoption of Paper-Based Diagnostic Solutions
    • Technological Innovations in Immunoassay and Lateral Flow Techniques Enhance the Versatility and Speed of Paper Diagnostics
    • Growing Adoption of Paper Diagnostics in Remote and Resource-Limited Regions Strengthens Global Healthcare Access
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Paper Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Paper Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Paper Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Paper Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Lateral Flow Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Lateral Flow Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Lateral Flow Assay Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Dipsticks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Home Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Paper Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Paper Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Paper Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION